Sylvia C Kurz Selected Research

Sylvia C Kurz Research Topics

9	Neoplasms (Cancer) 01/2023 - 04/2018
8	Glioma (Gliomas) 02/2024 - 04/2018
7	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 04/2018
4	Brain Neoplasms (Brain Tumor) 01/2024 - 02/2021
2	Meningioma (Meningiomas) 12/2023 - 01/2020
1	Venous Thromboembolism 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Leukoencephalopathies 10/2023
1	Lymphoma (Lymphomas) 10/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Oligodendroglioma 02/2021

3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
2	Bevacizumab (Avastin)FDA Link 10/2018 - 04/2018
2	NivolumabIBA 10/2018 - 04/2018
1	TIC10 compoundIBA 02/2024
1	Histones (Histone)IBA 02/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2024
1	AnticoagulantsIBA 01/2024
1	Heparin (Liquaemin)FDA LinkGeneric 01/2024
1	gallium Ga 68 dotatateIBA 12/2023
1	lutetium Lu 177 dotatateIBA 12/2023
1	RadiopharmaceuticalsIBA 12/2023
1	somatostatin receptor 2IBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 10/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	adagrasibIBA 01/2022
1	Lomustine (CCNU)FDA Link 02/2021
1	Procarbazine (Matulane)FDA Link 02/2021
1	Vincristine (Oncovin)FDA LinkGeneric 02/2021
1	Temozolomide (Temodar)FDA LinkGeneric 08/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	AntigensIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	rovalpituzumab tesirineIBA 01/2019
1	LigandsIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 10/2018
1	AntibodiesIBA 10/2018
1	pembrolizumabIBA 10/2018
1	epidermal growth factor receptor VIIIIBA 04/2018